{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:04:56Z","timestamp":1790478296348,"version":"4.1.0"},"reference-count":247,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Robert J. Kleberg and Helen C. Kleberg Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"NIH\/NIAID","award":["R01 AI 146340"],"award-info":[{"award-number":["R01 AI 146340"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The current emergence of multi-, extensively-, extremely-, and total-drug resistant strains of Mycobacterium tuberculosis poses a major health, social, and economic threat, and stresses the need to develop new therapeutic strategies. The notion of phage therapy against bacteria has been around for more than a century and, although its implementation was abandoned after the introduction of drugs, it is now making a comeback and gaining renewed interest in Western medicine as an alternative to treat drug-resistant pathogens. Mycobacteriophages are genetically diverse viruses that specifically infect mycobacterial hosts, including members of the M. tuberculosis complex. This review describes general features of mycobacteriophages and their mechanisms of killing M. tuberculosis, as well as their advantages and limitations as therapeutic and prophylactic agents against drug-resistant M. tuberculosis strains. This review also discusses the role of human lung micro-environments in shaping the availability of mycobacteriophage receptors on the M. tuberculosis cell envelope surface, the risk of potential development of bacterial resistance to mycobacteriophages, and the interactions with the mammalian host immune system. Finally, it summarizes the knowledge gaps and defines key questions to be addressed regarding the clinical application of phage therapy for the treatment of drug-resistant tuberculosis.<\/jats:p>","DOI":"10.3390\/ijms22020735","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T11:52:32Z","timestamp":1610538752000},"page":"735","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis"],"prefix":"10.3390","volume":"22","author":[{"given":"Anna","family":"Allu\u00e9-Guardia","sequence":"first","affiliation":[{"name":"Population Health Program, Tuberculosis Group, Texas Biomedical Research Institute, San Antonio, TX 78227, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajagopalan","family":"Saranathan","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10461, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7702-5941","authenticated-orcid":false,"given":"Jordi B.","family":"Torrelles","sequence":"additional","affiliation":[{"name":"Population Health Program, Tuberculosis Group, Texas Biomedical Research Institute, San Antonio, TX 78227, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"ref_1","unstructured":"WHO (2020). Global Tuberculosis Report 2020, WHO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4049\/jimmunol.1100823","article-title":"Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection","volume":"187","author":"Arcos","year":"2011","journal-title":"J. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.tim.2017.03.007","article-title":"Integrating Lung Physiology, Immunology, and Tuberculosis","volume":"25","author":"Torrelles","year":"2017","journal-title":"Trends Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3329\/jhpn.v28i2.4879","article-title":"Tuberculosis: A global health problem","volume":"28","author":"Zaman","year":"2010","journal-title":"J. Health Popul. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1752-8062.2008.00060.x","article-title":"The emergence of extensively drug-resistant tuberculosis: A global health crisis requiring new interventions: Part I: The origins and nature of the problem","volume":"1","author":"Ellner","year":"2008","journal-title":"Clin. Transl. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)60085-3","article-title":"India reports cases of totally drug-resistant tuberculosis","volume":"379","author":"Loewenberg","year":"2012","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3201\/eid1903.120246","article-title":"Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa","volume":"19","author":"Klopper","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/QCO.0b013e3283229fab","article-title":"Extensively drug-resistant tuberculosis","volume":"22","author":"LoBue","year":"2009","journal-title":"Curr. Opin Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.08-2427","article-title":"Emergence of new forms of totally drug-resistant tuberculosis bacilli: Super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran","volume":"136","author":"Velayati","year":"2009","journal-title":"Chest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/cis128","article-title":"Totally drug-resistant and extremely drug-resistant tuberculosis: The same disease?","volume":"54","author":"Migliori","year":"2012","journal-title":"Clin. Infect. Dis"},{"key":"ref_11","unstructured":"WHO (2020, March 03). Drug-Resistant TB: Totally Drug-Resistant TB FAQ. Available online: https:\/\/www.who.int\/tb\/areas-of-work\/drug-resistant-tb\/totally-drug-resistant-tb-faq\/en\/."},{"key":"ref_12","first-page":"307","article-title":"The totally drug resistant tuberculosis (TDR-TB)","volume":"6","author":"Velayati","year":"2013","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Burki, T.K. (2017). The uphill battle to find new TB treatments. Lancet Respir Med.","DOI":"10.1016\/S2213-2600(17)30086-3"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/resp.13304","article-title":"Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment","volume":"23","author":"Lange","year":"2018","journal-title":"Respirology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1183\/09031936.00081909","article-title":"Totally drug-resistant tuberculosis strains: Evidence of adaptation at the cellular level","volume":"34","author":"Velayati","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1017\/S002572730006782X","article-title":"Felix d\u2019Herelle and the origins of molecular biology","volume":"45","author":"Wilkinson","year":"2001","journal-title":"Med. Hist."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","article-title":"Phage Therapy-History from Twort and d\u2019Herelle Through Soviet Experience to Current Approaches","volume":"83","author":"Chanishvili","year":"2012","journal-title":"Adv. Virus Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1128\/AAC.45.3.649-659.2001","article-title":"Bacteriophage therapy","volume":"45","author":"Sulakvelidze","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1155\/2007\/365761","article-title":"The epic of phage therapy","volume":"18","author":"Dublanchet","year":"2007","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_20","unstructured":"Kokin, G.A. (1946). Phage therapy and phage prophylaxis of gas gangrene. Experience of the Soviet Military Medicine during the Great Patriotic War 1941\u20131945, Medgiz."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: An alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Merabishvili, M., Pirnay, J.P., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N., Glonti, T., Krylov, V., Mast, J., and Van Parys, L. (2009). Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004944"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-4362.2002.01451.x","article-title":"A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds","volume":"41","author":"Markoishvili","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1111\/1462-2920.14310","article-title":"Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo-controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers","volume":"20","author":"McCallin","year":"2018","journal-title":"Environ. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Villarroel, J., Larsen, M.V., Kilstrup, M., and Nielsen, M. (2017). Metagenomic Analysis of Therapeutic PYO Phage Cocktails from 1997 to 2014. Viruses, 9.","DOI":"10.3390\/v9110328"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12250-014-3557-0","article-title":"Experience of the Eliava Institute in bacteriophage therapy","volume":"30","author":"Kutateladze","year":"2015","journal-title":"Virol. Sin."},{"key":"ref_27","first-page":"766","article-title":"Bacteriophage therapy for the treatment of infections","volume":"10","author":"Gorski","year":"2009","journal-title":"Curr. Opin Investig. Drugs"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fcimb.2018.00376","article-title":"Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles","volume":"8","author":"Furfaro","year":"2018","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wienhold, S.M., Lienau, J., and Witzenrath, M. (2019). Towards Inhaled Phage Therapy in Western Europe. Viruses, 11.","DOI":"10.3390\/v11030295"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1128\/AEM.02195-08","article-title":"Use of a bacteriophage lysin, PlyC, as an enzyme disinfectant against Streptococcus equi","volume":"75","author":"Hoopes","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/B978-0-12-394598-3.00006-X","article-title":"Bacteriophages for detection and control of bacterial pathogens in food and food-processing environment","volume":"67","author":"Brovko","year":"2012","journal-title":"Adv. Food Nutr. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3389\/fpls.2017.01218","article-title":"Bacteriophage-Based Bacterial Wilt Biocontrol for an Environmentally Sustainable Agriculture","volume":"8","author":"Alvarez","year":"2017","journal-title":"Front. Plant. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tseng, C.C., Chang, D.C., and Chang, K.C. (2019). Development of a Biocontrol Method Applying Bacteriophage-Containing Aerosol against Mycobacterium tuberculosis Using the Bacteriophage BTCU-1 and M. smegmatis as Models. Microorganisms, 7.","DOI":"10.3390\/microorganisms7080237"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Stone, E., Campbell, K., Grant, I., and McAuliffe, O. (2019). Understanding and Exploiting Phage-Host Interactions. Viruses, 11.","DOI":"10.3390\/v11060567"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tube.2017.12.002","article-title":"Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance","volume":"109","author":"Lohrasbi","year":"2018","journal-title":"Tuberculosis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"ofy064","DOI":"10.1093\/ofid\/ofy064","article-title":"Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection","volume":"5","author":"LaVergne","year":"2018","journal-title":"Open Forum. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Jeon, J., Park, J.H., and Yong, D. (2019). Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia. BMC Microbiol., 19.","DOI":"10.1186\/s12866-019-1443-5"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/AAC.00924-19","article-title":"Bacteriophages as adjuvant to antibiotics for the treatment of periprosthetic joint infection caused by multidrug-resistant Pseudomonas aeruginosa","volume":"64","author":"Tkhilaishvili","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3181\/00379727-66-16037","article-title":"A bacteriophage for Mycobacterium smegmatis","volume":"66","author":"Gardner","year":"1947","journal-title":"Proc. Soc. Exp. Biol Med."},{"key":"ref_42","first-page":"215","article-title":"Phage typing of South Indian M. tuberculosis strains by \u201csurface\u201d and \u201coverlay\u201d method","volume":"4","author":"Sula","year":"1981","journal-title":"Czech. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0041-3879(83)90045-4","article-title":"Bacteriophage typing of strains of Mycobacterium tuberculosis from Nepal","volume":"64","author":"Goode","year":"1983","journal-title":"Tubercle"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/228280b0","article-title":"Transduction in Mycobacterium smegmatis","volume":"228","author":"Raj","year":"1970","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1099\/00222615-8-3-389","article-title":"Ultrastructure of L-phase variants isolated from a culture of Mycobacterium phlei","volume":"8","author":"Imaeda","year":"1975","journal-title":"J. Med. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/jvi.27.2.432-435.1978","article-title":"Structure of native and chloroform-methanol-treated mycobacteriophage R1","volume":"27","author":"Fay","year":"1978","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1139\/m68-093","article-title":"Lysogeny in mycobacteria. I. Conversion of colony morphology, nitrate reductase activity, and tween 80 hydrolysis of Mycobacterium sp. ATCC 607 associated with lysogeny","volume":"14","author":"Jones","year":"1968","journal-title":"Can. J. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1432-1033.1977.tb11312.x","article-title":"Chemical and physical properties of mycobacteriophage D29","volume":"73","author":"Schafer","year":"1977","journal-title":"Eur. J. Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1073\/pnas.94.20.10961","article-title":"Conditionally replicating mycobacteriophages: A system for transposon delivery to Mycobacterium tuberculosis","volume":"94","author":"Bardarov","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2958.1993.tb01131.x","article-title":"DNA sequence, structure and gene expression of mycobacteriophage L5: A phage system for mycobacterial genetics","volume":"7","author":"Hatfull","year":"1993","journal-title":"Mol. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/327532a0","article-title":"Introduction of foreign DNA into mycobacteria using a shuttle phasmid","volume":"327","author":"Jacobs","year":"1987","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Jacobs, W.R. (2014). Gene Transfer in Mycobacterium tuberculosis: Shuttle Phasmids to Enlightenment. Microbiol. Spectr., 2.","DOI":"10.1128\/microbiolspec.MGM2-0037-2013"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.femsle.2004.10.032","article-title":"Bxz1, a new generalized transducing phage for mycobacteria","volume":"241","author":"Lee","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-2958.2008.06109.x","article-title":"Efficient point mutagenesis in mycobacteria using single-stranded DNA recombineering: Characterization of antimycobacterial drug targets","volume":"67","author":"Hatfull","year":"2008","journal-title":"Mol. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.MGM2-0032-2013","article-title":"Molecular Genetics of Mycobacteriophages","volume":"2","author":"Hatfull","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fcimb.2018.00385","article-title":"CitE Enzymes Are Essential for Mycobacterium tuberculosis to Establish Infection in Macrophages and Guinea Pigs","volume":"8","author":"Arora","year":"2018","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-8940-9_6","article-title":"Genetic Manipulation of Lytic Bacteriophages with BRED: Bacteriophage Recombineering of Electroporated DNA","volume":"1898","author":"Marinelli","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1099\/mic.0.000120","article-title":"Mycobacteriophage-repressor-mediated immunity as a selectable genetic marker: Adephagia and BPs repressor selection","volume":"161","author":"Petrova","year":"2015","journal-title":"Microbiology"},{"key":"ref_59","first-page":"69","article-title":"Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin","volume":"4","author":"McNerney","year":"2000","journal-title":"Int. J. Tuberc Lung Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/21505594.2016.1191729","article-title":"Evidence of Mycobacterium tuberculosis complex bacteraemia in intradermal skin test positive cattle detected using phage-RPA","volume":"7","author":"Swift","year":"2016","journal-title":"Virulence"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.8484123","article-title":"Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages","volume":"260","author":"Jacobs","year":"1993","journal-title":"Science"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1128\/jcm.35.12.3232-3239.1997","article-title":"Conditionally replicating luciferase reporter phages: Improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis","volume":"35","author":"Carriere","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1128\/jcm.35.12.3225-3231.1997","article-title":"Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: Use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone","volume":"35","author":"Riska","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Jain, P., Garing, S., Verma, D., Saranathan, R., Clute-Reinig, N., Gadwa, J., Peterson, C., Hermansky, G., Astashkina Fernandez, A., and Asare, E. (2020). Nanoluciferase Reporter Mycobacteriophage for Sensitive and Rapid Detection of Mycobacterium tuberculosis Drug Susceptibility. J. Bacteriol., 202.","DOI":"10.1128\/JB.00411-20"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Piuri, M., Jacobs, W.R., and Hatfull, G.F. (2009). Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004870"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/ijmy.ijmy_47_19","article-title":"A rapid viability and drug-susceptibility assay utilizing mycobacteriophage as an indicator of drug susceptibilities of Anti-TB drugs against Mycobacterium smegmatis mc(2) 155","volume":"8","author":"Crowley","year":"2019","journal-title":"Int. J. Mycobacteriol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3389\/fmicb.2018.01471","article-title":"Fluoromycobacteriophages Can Detect Viable Mycobacterium tuberculosis and Determine Phenotypic Rifampicin Resistance in 3-5 Days From Sputum Collection","volume":"9","author":"Rondon","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-8940-9_2","article-title":"Fluoromycobacteriophages for Drug Susceptibility Testing (DST) of Mycobacteria","volume":"1898","author":"Piuri","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell, M.R., Larsen, M.H., Brown, T.S., Jain, P., Munsamy, V., Wolf, A., Uccellini, L., Karim, F., de Oliveira, T., and Mathema, B. (2019). Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow Cytometry-Based Phenotyping and Whole-Genome Sequencing. Antimicrob. Agents Chemother., 63.","DOI":"10.1128\/AAC.01834-18"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e01023-16","DOI":"10.1128\/mBio.01023-16","article-title":"Dual-Reporter Mycobacteriophages (Phi2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum","volume":"7","author":"Jain","year":"2016","journal-title":"MBio"},{"key":"ref_71","unstructured":"Hatfull, G.F., Russell, D., Jacobs-Sera, D., Pope, W.H., and Sivanathan, V. (2020, March 03). The Actinobacteriophage Database. Available online: https:\/\/phagesdb.org\/hosts\/genera\/1\/."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/bioinformatics\/btw711","article-title":"PhagesDB: The actinobacteriophage database","volume":"33","author":"Russell","year":"2017","journal-title":"Bioinformatics"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1139\/cjm-2017-0387","article-title":"Isolation and characterization of bacteriophages from India, with lytic activity against Mycobacterium tuberculosis","volume":"64","author":"Bajpai","year":"2018","journal-title":"Can. J. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/ijmy.ijmy_42_19","article-title":"Study of characteristics of mycobacteriophage\u2014A novel tool to treat Mycobacterium spp.","volume":"8","author":"Satish","year":"2019","journal-title":"Int. J. Mycobacteriol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0065-3527(08)60785-X","article-title":"Tailed bacteriophages: The order caudovirales","volume":"51","author":"Ackermann","year":"1998","journal-title":"Adv. Virus Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41579-019-0311-5","article-title":"Phage diversity, genomics and phylogeny","volume":"18","author":"Dion","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Hatfull, G.F. (2018). Mycobacteriophages. Microbiol. Spectr., 6.","DOI":"10.1128\/microbiolspec.GPP3-0026-2018"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e06416","DOI":"10.7554\/eLife.06416","article-title":"Whole genome comparison of a large collection of mycobacteriophages reveals a continuum of phage genetic diversity","volume":"4","author":"Pope","year":"2015","journal-title":"Elife"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(03)00233-2","article-title":"Origins of highly mosaic mycobacteriophage genomes","volume":"113","author":"Pedulla","year":"2003","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Hatfull, G.F., Pedulla, M.L., Jacobs-Sera, D., Cichon, P.M., Foley, A., Ford, M.E., Gonda, R.M., Houtz, J.M., Hryckowian, A.J., and Kelchner, V.A. (2006). Exploring the mycobacteriophage metaproteome: Phage genomics as an educational platform. PLoS Genet., 2.","DOI":"10.1371\/journal.pgen.0020092"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.micro.112408.134233","article-title":"Mycobacteriophages: Genes and genomes","volume":"64","author":"Hatfull","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/mmi.13414","article-title":"Function, expression, specificity, diversity and incompatibility of actinobacteriophage parABS systems","volume":"101","author":"Dedrick","year":"2016","journal-title":"Mol. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3389\/fmicb.2018.01042","article-title":"Beyond the Limits: tRNA Array Units in Mycobacterium Genomes","volume":"9","author":"Morgado","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e01537-16","DOI":"10.1128\/mBio.01537-16","article-title":"Mycobacteriophages as Incubators for Intein Dissemination and Evolution","volume":"7","author":"Kelley","year":"2016","journal-title":"MBio"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jmb.2010.01.011","article-title":"Comparative genomic analysis of 60 Mycobacteriophage genomes: Genome clustering, gene acquisition, and gene size","volume":"397","author":"Hatfull","year":"2010","journal-title":"J. Mol. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/mmi.13946","article-title":"Mycobacteriophage Fruitloop gp52 inactivates Wag31 (DivIVA) to prevent heterotypic superinfection","volume":"108","author":"Ko","year":"2018","journal-title":"Mol. Microbiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1038\/s41598-020-71588-5","article-title":"Identification of mycobacteriophage toxic genes reveals new features of mycobacterial physiology and morphology","volume":"10","author":"Ko","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"16251","DOI":"10.1038\/nmicrobiol.2016.251","article-title":"Prophage-mediated defence against viral attack and viral counter-defence","volume":"2","author":"Dedrick","year":"2017","journal-title":"Nat. Microbiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e00196-19","DOI":"10.1128\/mBio.00196-19","article-title":"More Evidence of Collusion: A New Prophage-Mediated Viral Defense System Encoded by Mycobacteriophage Sbash","volume":"10","author":"Gentile","year":"2019","journal-title":"MBio"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e00971-19","DOI":"10.1128\/mBio.00971-19","article-title":"Evolution of Superinfection Immunity in Cluster A Mycobacteriophages","volume":"10","author":"Mavrich","year":"2019","journal-title":"MBio"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Lima-Junior, J.D., Viana-Niero, C., Conde Oliveira, D.V., Machado, G.E., Rabello, M.C., Martins-Junior, J., Martins, L.F., Digiampietri, L.A., da Silva, A.M., and Setubal, J.C. (2016). Characterization of mycobacteria and mycobacteriophages isolated from compost at the Sao Paulo Zoo Park Foundation in Brazil and creation of the new mycobacteriophage Cluster U. BMC Microbiol., 16.","DOI":"10.1186\/s12866-016-0734-3"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Suarez, C.A., Franceschelli, J.J., and Morbidoni, H.R. (2019). Mycobacteriophage CRB2 defines a new subcluster in mycobacteriophage classification. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0212365"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Fast, K.M., Keener, T., Ali, R., Butcher, B.M., Millwood, J.D., Odom, T., Schellhammer, P.K., Ufomadu, E., and Sandel, M.W. (2018). Genome Sequence of a Newly Isolated F2 Subcluster Mycobacteriophage from the Black Belt Geological Region of Western Alabama. Genome Announc., 6.","DOI":"10.1128\/genomeA.01555-17"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00894-016-3056-3","article-title":"Homology modeling, substrate docking, and molecular simulation studies of mycobacteriophage Che12 lysin A","volume":"22","author":"Saadhali","year":"2016","journal-title":"J. Mol. Model."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Pimentel, M. (2014). Genetics of Phage Lysis. Microbiol. Spectr., 2.","DOI":"10.1128\/microbiolspec.MGM2-0017-2013"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1099\/mic.0.000831","article-title":"Understanding the role of the lysozyme-like domain of D29 mycobacteriophage-encoded endolysin in host cell lysis and phage propagation","volume":"165","author":"Joshi","year":"2019","journal-title":"Microbiology"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Catalao, M.J., and Pimentel, M. (2018). Mycobacteriophage Lysis Enzymes: Targeting the Mycobacterial Cell Envelope. Viruses, 10.","DOI":"10.3390\/v10080428"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1002\/1873-3468.12848","article-title":"Dissecting the structure-function relationship in lysozyme domain of mycobacteriophage D29-encoded peptidoglycan hydrolase","volume":"591","author":"Joshi","year":"2017","journal-title":"FEBS Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fmicb.2020.00883","article-title":"Deciphering the Role of Holin in Mycobacteriophage D29 Physiology","volume":"11","author":"Bavda","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2958.2010.07239.x","article-title":"The mycobacteriophage Ms6 encodes a chaperone-like protein involved in the endolysin delivery to the peptidoglycan","volume":"77","author":"Catalao","year":"2010","journal-title":"Mol. Microbiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41579-019-0273-7","article-title":"The mycobacterial cell envelope\u2014A moving target","volume":"18","author":"Dulberger","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Gigante, A.M., Hampton, C.M., Dillard, R.S., Gil, F., Catalao, M.J., Moniz-Pereira, J., Wright, E.R., and Pimentel, M. (2017). The Ms6 Mycolyl-Arabinogalactan Esterase LysB is Essential for an Efficient Mycobacteriophage-Induced Lysis. Viruses, 9.","DOI":"10.3390\/v9110343"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2958.2009.06775.x","article-title":"Mycobacteriophage Lysin B is a novel mycolylarabinogalactan esterase","volume":"73","author":"Payne","year":"2009","journal-title":"Mol. Microbiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1099\/mic.0.032821-0","article-title":"Mycobacteriophage Ms6 LysB specifically targets the outer membrane of Mycobacterium smegmatis","volume":"156","author":"Gil","year":"2010","journal-title":"Microbiology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3389\/fimmu.2019.02909","article-title":"Underestimated Manipulative Roles of Mycobacterium tuberculosis Cell Envelope Glycolipids During Infection","volume":"10","author":"Chan","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Fraga, A.G., Trigo, G., Murthy, R.K., Akhtar, S., Hebbur, M., Pacheco, A.R., Dominguez, J., Silva-Gomes, R., Goncalves, C.M., and Oliveira, H. (2019). Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection. PLoS Negl. Trop Dis., 13.","DOI":"10.1371\/journal.pntd.0007113"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/AEM.02700-15","article-title":"Dynamics of Mycobacteriophage-Mycobacterial Host Interaction: Evidence for Secondary Mechanisms for Host Lethality","volume":"82","author":"Samaddar","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Van Belleghem, J.D., Dabrowska, K., Vaneechoutte, M., Barr, J.J., and Bollyky, P.L. (2018). Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System. Viruses, 11.","DOI":"10.3390\/v11010010"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1128\/AAC.04641-14","article-title":"Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model","volume":"59","author":"Lood","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jac\/dkv038","article-title":"A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae","volume":"70","author":"Bustamante","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13568-019-0838-x","article-title":"External lysis of Escherichia coli by a bacteriophage endolysin modified with hydrophobic amino acids","volume":"9","author":"Yan","year":"2019","journal-title":"AMB Express"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"12087","DOI":"10.1038\/s41598-020-68983-3","article-title":"Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria","volume":"10","author":"Zampara","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-981-13-7709-9_11","article-title":"Enzybiotics: Enzyme-Based Antibacterials as Therapeutics","volume":"1148","author":"Dams","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fmicb.2019.00190","article-title":"Revisiting Anti-tuberculosis Therapeutic Strategies That Target the Peptidoglycan Structure and Synthesis","volume":"10","author":"Catalao","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"28701","DOI":"10.1038\/srep28701","article-title":"Mycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1042\/BST20180506","article-title":"Bacteriophage gene products as potential antimicrobials against tuberculosis","volume":"47","author":"Puiu","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1099\/mic.0.000810","article-title":"A mycobacteriophage genomics approach to identify novel mycobacteriophage proteins with mycobactericidal properties","volume":"165","author":"Singh","year":"2019","journal-title":"Microbiology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1074\/jbc.RA118.006968","article-title":"A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities","volume":"294","author":"Yang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Casey, E., van Sinderen, D., and Mahony, J. (2018). In Vitro Characteristics of Phages to Guide \u2018Real Life\u2019 Phage Therapy Suitability. Viruses, 10.","DOI":"10.3390\/v10040163"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.00635-06","article-title":"Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice","volume":"51","author":"Watanabe","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.vetmic.2010.05.014","article-title":"Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: A before\/after clinical trial","volume":"146","author":"Hawkins","year":"2010","journal-title":"Vet. Microbiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-12-394438-2.00004-9","article-title":"Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice","volume":"83","author":"Saussereau","year":"2012","journal-title":"Adv. Virus Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/emph\/eoy005","article-title":"Phage treatment of an aortic graft infected with Pseudomonas aeruginosa","volume":"2018","author":"Chan","year":"2018","journal-title":"Evol. Med. Public Health"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): A randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/AAC.49.3.1220-1221.2005","article-title":"Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model","volume":"49","author":"Wills","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1099\/jmm.0.2008\/002873-0","article-title":"Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice","volume":"57","author":"Chhibber","year":"2008","journal-title":"J. Med. Microbiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1099\/00222615-37-4-258","article-title":"Treatment of experimental infections of mice with bacteriophages","volume":"37","author":"Soothill","year":"1992","journal-title":"J. Med. Microbiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/AAC.01774-15","article-title":"Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo","volume":"60","author":"Nale","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1128\/AEM.00099-06","article-title":"Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants","volume":"72","author":"Sheng","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_131","first-page":"175","article-title":"Bacteriophage treatment of suppurative skin infections","volume":"35","author":"Cislo","year":"1987","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3389\/fphar.2019.00513","article-title":"Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections","volume":"10","author":"Principi","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2217\/fmb-2017-0261","article-title":"Phages & antibiotic resistance: Are the most abundant entities on earth ready for a comeback?","volume":"13","author":"Hill","year":"2018","journal-title":"Future Microbiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.12968\/jowc.2016.25.7.S27","article-title":"Bacteriophage treatment of intransigent diabetic toe ulcers: A case series","volume":"25","author":"Fish","year":"2016","journal-title":"J. Wound Care"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy","volume":"34","author":"Wright","year":"2009","journal-title":"Clin. Otolaryngol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/infdis\/jiu059","article-title":"Bacteriophage therapy of a Vibrio parahaemolyticus infection caused by a multiple-antibiotic-resistant O3:K6 pandemic clinical strain","volume":"210","author":"Jun","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"26717","DOI":"10.1038\/srep26717","article-title":"Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa","volume":"6","author":"Chan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.2147\/IDR.S218638","article-title":"Phage therapy as a renewed therapeutic approach to mycobacterial infections: A comprehensive review","volume":"12","author":"Azimi","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_139","first-page":"209","article-title":"Therapy of experimental tuberculosis in guinea pigs with mycobacterial phages DS-6A, GR-21 T, My-327","volume":"4","author":"Sula","year":"1981","journal-title":"Czech. Med."},{"key":"ref_140","first-page":"733","article-title":"Therapeutic effect of bacteriophage D29 in the treatment for guinea pigs infected with sensitive strain of Mycobacterium tuberculosis","volume":"25","author":"Peng","year":"2009","journal-title":"Chin. J. Zoonoses"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Gordillo Altamirano, F.L., and Barr, J.J. (2019). Phage Therapy in the Postantibiotic Era. Clin. Microbiol. Rev., 32.","DOI":"10.1128\/CMR.00066-18"},{"key":"ref_142","first-page":"723","article-title":"Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus","volume":"145","author":"Ooi","year":"2019","journal-title":"JAMA Otolaryngol."},{"key":"ref_143","unstructured":"Bogovazova, G.G., Voroshilova, N.N., and Bondarenko, V.M. (1991). The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection. Zh. Mikrobiol. Epidemiol. Immunobiol., 5\u20138."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fmicb.2015.00381","article-title":"Multidimensional metrics for estimating phage abundance, distribution, gene density, and sequence coverage in metagenomes","volume":"6","author":"Aziz","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.mib.2008.09.004","article-title":"Bacteriophage genomics","volume":"11","author":"Hatfull","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.idairyj.2012.07.010","article-title":"Isolation and characterisation of six novel mycobacteriophages and investigation of their antimicrobial potential in milk","volume":"28","author":"Endersen","year":"2013","journal-title":"Int. Dairy J."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Caratenuto, R.A., Ciabattoni, G.O., DesGranges, N.J., Drost, C.L., Gao, L., Gipson, B., Kahler, N.C., Kirven, N.A., Melehani, J.C., and Patel, K. (2019). Genome Sequences of Six Cluster N Mycobacteriophages, Kevin1, Nenae, Parmesanjohn, ShrimpFriedEgg, Smurph, and SpongeBob, Isolated on Mycobacterium smegmatis mc(2)155. Microbiol. Resour. Announc., 8.","DOI":"10.1128\/MRA.00399-19"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/285884","article-title":"Phage therapy revisited: The population biology of a bacterial infection and its treatment with bacteriophage and antibiotics","volume":"147","author":"Levin","year":"1996","journal-title":"Am. Nat."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.aad6791","article-title":"MICROBIOLOGY. Phage therapy redux--What is to be done?","volume":"350","author":"Young","year":"2015","journal-title":"Science"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tube.2019.01.002","article-title":"Mycobacteriophage ZoeJ: A broad host-range close relative of mycobacteriophage TM4","volume":"115","author":"Dedrick","year":"2019","journal-title":"Tuberculosis"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/JB.00592-16","article-title":"Fluorescent Reporter DS6A Mycobacteriophages Reveal Unique Variations in Infectibility and Phage Production in Mycobacteria","volume":"198","author":"Mayer","year":"2016","journal-title":"J. Bacteriol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/jmm.0.46238-0","article-title":"Host range of 14 mycobacteriophages in Mycobacterium ulcerans and seven other mycobacteria including Mycobacterium tuberculosis\u2014Application for identification and susceptibility testing","volume":"55","author":"Rybniker","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s10517-018-3986-0","article-title":"Evaluation of the Efficiency of Lytic Mycobacteriophage D29 on the Model of M. tuberculosis-Infected Macrophage RAW 264 Cell Line","volume":"164","author":"Lapenkova","year":"2018","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Carrigy, N.B., Larsen, S.E., Reese, V., Pecor, T., Harrison, M., Kuehl, P.J., Hatfull, G.F., Sauvageau, D., Baldwin, S.L., and Finlay, W.H. (2019). Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29. Antimicrob. Agents Chemother., 63.","DOI":"10.1128\/AAC.00871-19"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/jamp.2015.1233","article-title":"Inhalation Study of Mycobacteriophage D29 Aerosol for Mice by Endotracheal Route and Nose-Only Exposure","volume":"29","author":"Liu","year":"2016","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2012.09.026","article-title":"On the nature of mycobacteriophage diversity and host preference","volume":"434","author":"Marinelli","year":"2012","journal-title":"Virology"},{"key":"ref_157","first-page":"5","article-title":"Genetic Diversity of Mycobacteriophages and the Unique Abilities of Cluster K","volume":"1","author":"Morris","year":"2017","journal-title":"Corinthian"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tim.2018.08.006","article-title":"Molecular and Evolutionary Determinants of Bacteriophage Host Range","volume":"27","author":"Nobrega","year":"2019","journal-title":"Trends Microbiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1534\/genetics.108.090100","article-title":"Bacteriophage adsorption rate and optimal lysis time","volume":"180","author":"Shao","year":"2008","journal-title":"Genetics"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Cebria-Mendoza, M., Sanjuan, R., and Domingo-Calap, P. (2019). Directed Evolution of a Mycobacteriophage. Antibiotics, 8.","DOI":"10.3390\/antibiotics8020046"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1099\/mic.0.033209-0","article-title":"Defects in glycopeptidolipid biosynthesis confer phage I3 resistance in Mycobacterium smegmatis","volume":"155","author":"Chen","year":"2009","journal-title":"Microbiology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1128\/jb.111.2.404-411.1972","article-title":"Nature of the receptor substance of Mycobacterium smegmatis for D4 bacteriophage adsorption","volume":"111","author":"Furuchi","year":"1972","journal-title":"J. Bacteriol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"11812","DOI":"10.1021\/bi961055+","article-title":"Chemistry of the lyxose-containing mycobacteriophage receptors of Mycobacterium phlei\/Mycobacterium smegmatis","volume":"35","author":"Khoo","year":"1996","journal-title":"Biochemistry"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.1128\/JVI.01209-13","article-title":"The first structure of a mycobacteriophage, the Mycobacterium abscessus subsp. bolletii phage Araucaria","volume":"87","author":"Sassi","year":"2013","journal-title":"J. Virol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"e960346","DOI":"10.4161\/21597073.2014.960346","article-title":"Mycobacteriophage cell binding proteins for the capture of mycobacteria","volume":"4","author":"Arutyunov","year":"2014","journal-title":"Bacteriophage"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.2001888117","article-title":"High-throughput discovery of phage receptors using transposon insertion sequencing of bacteria","volume":"117","author":"Kortright","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Vilcheze, C., Copeland, J., Keiser, T.L., Weisbrod, T., Washington, J., Jain, P., Malek, A., Weinrick, B., and Jacobs, W.R. (2018). Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy. mBio, 9.","DOI":"10.1128\/mBio.00938-18"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.celrep.2019.09.062","article-title":"Reprogramming Bacteriophage Host Range through Structure-Guided Design of Chimeric Receptor Binding Proteins","volume":"29","author":"Dunne","year":"2019","journal-title":"Cell Rep."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/fpd.2005.2.287","article-title":"Evolution of foodborne pathogens via temperate bacteriophage-mediated gene transfer","volume":"2","author":"Brabban","year":"2005","journal-title":"Foodborne Pathog. Dis."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1038\/ncomms13333","article-title":"Bacterial viruses enable their host to acquire antibiotic resistance genes from neighbouring cells","volume":"7","author":"Haaber","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Sweere, J.M., Van Belleghem, J.D., Ishak, H., Bach, M.S., Popescu, M., Sunkari, V., Kaber, G., Manasherob, R., Suh, G.A., and Cao, X. (2019). Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science, 363.","DOI":"10.1126\/science.aat9691"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41385-019-0156-2","article-title":"The human lung mucosa drives differential Mycobacterium tuberculosis infection outcome in the alveolar epithelium","volume":"12","author":"Scordo","year":"2019","journal-title":"Mucosal. Immunol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/mi.2016.115","article-title":"Mycobacterium tuberculosis cell wall released fragments by the action of the human lung mucosa modulate macrophages to control infection in an IL-10-dependent manner","volume":"10","author":"Arcos","year":"2017","journal-title":"Mucosal. Immunol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/jiz138","article-title":"The Lung Mucosa Environment in the Elderly Increases Host Susceptibility to Mycobacterium tuberculosis Infection","volume":"220","author":"Moliva","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/mi.2017.80","article-title":"Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8(+) T-cell-dependent manner","volume":"11","author":"Moliva","year":"2018","journal-title":"Mucosal. Immunol."},{"key":"ref_176","first-page":"411","article-title":"The granuloma in tuberculosis: Dynamics of a host-pathogen collusion","volume":"3","author":"Ehlers","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/mmi.14362","article-title":"Mycobacterium tuberculosis requires glyoxylate shunt and reverse methylcitrate cycle for lactate and pyruvate metabolism","volume":"112","author":"Serafini","year":"2019","journal-title":"Mol. Microbiol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","article-title":"Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection","volume":"16","author":"Bell","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fcimb.2019.00342","article-title":"Changes in Host Response to Mycobacterium tuberculosis Infection Associated With Type 2 Diabetes: Beyond Hyperglycemia","volume":"9","year":"2019","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_180","first-page":"74","article-title":"A study of the phage lysability of mycobacteria isolated in Africa","volume":"43","author":"Zykov","year":"1966","journal-title":"Zh Mikrobiol Epidemiol. Immunobiol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"e00588","DOI":"10.1002\/mbo3.588","article-title":"Quantifying intracellular Mycobacterium tuberculosis: An essential issue for in vitro assays","volume":"7","author":"Rodriguez","year":"2018","journal-title":"Microbiologyopen"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Nguyen, S., Baker, K., Padman, B.S., Patwa, R., Dunstan, R.A., Weston, T.A., Schlosser, K., Bailey, B., Lithgow, T., and Lazarou, M. (2017). Bacteriophage Transcytosis Provides a Mechanism To Cross Epithelial Cell Layers. mBio, 8.","DOI":"10.1128\/mBio.01874-17"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Morello, E., Saussereau, E., Maura, D., Huerre, M., Touqui, L., and Debarbieux, L. (2011). Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: First steps towards treatment and prevention. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016963"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1007\/s00253-014-5643-5","article-title":"Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages","volume":"98","author":"Kaur","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/343812","article-title":"Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: A model for phage therapy of intracellular bacterial pathogens","volume":"186","author":"Broxmeyer","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/mdr.2006.12.1","article-title":"In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium","volume":"12","author":"Danelishvili","year":"2006","journal-title":"Microb. Drug Resist."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nm.2420","article-title":"A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis","volume":"17","author":"Sweeney","year":"2011","journal-title":"Nat. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1517\/17425247.2015.1043125","article-title":"A first step toward liposome-mediated intracellular bacteriophage therapy","volume":"12","author":"Nieth","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/viro.2000.0809","article-title":"Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage","volume":"282","author":"Salone","year":"2001","journal-title":"Virology"},{"key":"ref_190","first-page":"221","article-title":"Mannose receptor","volume":"137B","author":"Pontow","year":"1992","journal-title":"Int. Rev. Cytol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/IAI.67.2.469-477.1999","article-title":"The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages","volume":"67","author":"Rittig","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1128\/AEM.01016-13","article-title":"Generation of affinity-tagged fluoromycobacteriophages by mixed assembly of phage capsids","volume":"79","author":"Piuri","year":"2013","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Rohde, C., Resch, G., Pirnay, J.P., Blasdel, B.G., Debarbieux, L., Gelman, D., Gorski, A., Hazan, R., Huys, I., and Kakabadze, E. (2018). Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains. Viruses, 10.","DOI":"10.3390\/v10040178"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.aas9430","article-title":"Microbial warfare against viruses","volume":"359","author":"Kim","year":"2018","journal-title":"Science"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Seed, K.D. (2015). Battling Phages: How Bacteria Defend against Viral Attack. PLoS Pathog, 11.","DOI":"10.1371\/journal.ppat.1004847"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrmicro2315","article-title":"Bacteriophage resistance mechanisms","volume":"8","author":"Labrie","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41586-019-1894-8","article-title":"The arms race between bacteria and their phage foes","volume":"577","author":"Hampton","year":"2020","journal-title":"Nature"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Maxwell, K.L. (2016). Phages Fight Back: Inactivation of the CRISPR-Cas Bacterial Immune System by Anti-CRISPR Proteins. PLoS Pathog, 12.","DOI":"10.1371\/journal.ppat.1005282"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"169","DOI":"10.15252\/embj.201489455","article-title":"BREX is a novel phage resistance system widespread in microbial genomes","volume":"34","author":"Goldfarb","year":"2015","journal-title":"Embo J."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Ofir, G., Melamed, S., Sberro, H., Mukamel, Z., Silverman, S., Yaakov, G., Doron, S., and Sorek, R. (2018). DISARM is a widespread bacterial defence system with broad anti-phage activities. Nat. Microbiol., 3.","DOI":"10.1038\/s41564-017-0051-0"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Torres-Barcelo, C. (2018). Phage Therapy Faces Evolutionary Challenges. Viruses, 10.","DOI":"10.3390\/v10060323"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/eva.12654","article-title":"Insights into the processes that drive the evolution of drug resistance in Mycobacterium tuberculosis","volume":"11","author":"Nguyen","year":"2018","journal-title":"Evol. Appl."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Capparelli, R., Nocerino, N., Lanzetta, R., Silipo, A., Amoresano, A., Giangrande, C., Becker, K., Blaiotta, G., Evidente, A., and Cimmino, A. (2010). Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011720"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-2672.2009.04462.x","article-title":"Exploitation of a new flagellatropic phage of Erwinia for positive selection of bacterial mutants attenuated in plant virulence: Towards phage therapy","volume":"108","author":"Evans","year":"2010","journal-title":"J. Appl. Microbiol."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Wright, R.C.T., Friman, V.P., Smith, M.C.M., and Brockhurst, M.A. (2018). Cross-resistance is modular in bacteria-phage interactions. PLoS Biol., 16.","DOI":"10.1371\/journal.pbio.2006057"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1128\/AEM.00757-12","article-title":"Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae","volume":"78","author":"Hall","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Chaudhry, W.N., Concepcion-Acevedo, J., Park, T., Andleeb, S., Bull, J.J., and Levin, B.R. (2017). Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0168615"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tim.2015.12.011","article-title":"Evolutionary Rationale for Phases as Complements of Antibiotics","volume":"24","author":"Hochberg","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_209","first-page":"703","article-title":"Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence","volume":"215","author":"Oechslin","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1752-4571.2011.00236.x","article-title":"Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms","volume":"5","author":"Zhang","year":"2012","journal-title":"Evol. Appl."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1574-695X.2012.00977.x","article-title":"Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro","volume":"65","author":"Ryan","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Cairns, J., Becks, L., Jalasvuori, M., and Hiltunen, T. (2017). Sublethal streptomycin concentrations and lytic bacteriophage together promote resistance evolution. Philos. Trans. R. Soc. Lond. B Biol. Sci., 372.","DOI":"10.1098\/rstb.2016.0040"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/AEM.02850-14","article-title":"Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): Antibiotics stimulate lytic phage activity","volume":"81","author":"Kamal","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Trasta, A. (2018). Personalized medicine and proper dosage: Over- and undertreatment of chronic diseases endanger patients\u2019 health and strain public health systems. EMBO Rep., 19.","DOI":"10.15252\/embr.201845957"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Hickey, A.J. (2016). Respirable Bacteriophage Aerosols for the Prevention and Treatment of Tuberculosis. Drug Delivery Systems for Tuberculosis Prevention and Treatment, John Wiley & Sons, Ltd.","DOI":"10.1002\/9781118943182"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ismej.2011.169","article-title":"Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome","volume":"6","author":"Pride","year":"2012","journal-title":"ISME J."},{"key":"ref_217","first-page":"14","article-title":"The human urine virome in association with urinary tract infections","volume":"6","author":"Ly","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3389\/fmicb.2017.00566","article-title":"Phages in the Human Body","volume":"8","author":"Navarro","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm.3950","article-title":"Early life dynamics of the human gut virome and bacterial microbiome in infants","volume":"21","author":"Lim","year":"2015","journal-title":"Nat. Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcf.2012.07.009","article-title":"Metagenomics and metatranscriptomics: Windows on CF-associated viral and microbial communities","volume":"12","author":"Lim","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.4049\/jimmunol.1701745","article-title":"Contribution of the Immune Response to Phage Therapy","volume":"200","author":"Krut","year":"2018","journal-title":"J. Immunol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1073\/pnas.1305923110","article-title":"Bacteriophage adhering to mucus provide a non-host-derived immunity","volume":"110","author":"Barr","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jmb.2006.03.043","article-title":"Ig-like domains on bacteriophages: A tale of promiscuity and deceit","volume":"359","author":"Fraser","year":"2006","journal-title":"J. Mol. Biol."},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Pope, W.H., Jacobs-Sera, D., Russell, D.A., Peebles, C.L., Al-Atrache, Z., Alcoser, T.A., Alexander, L.M., Alfano, M.B., Alford, S.T., and Amy, N.E. (2011). Expanding the diversity of mycobacteriophages: Insights into genome architecture and evolution. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016329"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"e1020260","DOI":"10.1080\/21597081.2015.1020260","article-title":"Phage therapy of pulmonary infections","volume":"5","author":"Abedon","year":"2015","journal-title":"Bacteriophage"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrmicro822","article-title":"Population and evolutionary dynamics of phage therapy","volume":"2","author":"Levin","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","article-title":"Formulation, stabilisation and encapsulation of bacteriophage for phage therapy","volume":"249","author":"Malik","year":"2017","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2019.01.003","article-title":"Bacteriophage interactions with mammalian tissue: Therapeutic applications","volume":"145","author":"Huh","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/med.21572","article-title":"Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review","volume":"39","author":"Dabrowska","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s11095-017-2213-4","article-title":"Anti-Tuberculosis Bacteriophage D29 Delivery with a Vibrating Mesh Nebulizer, Jet Nebulizer, and Soft Mist Inhaler","volume":"34","author":"Carrigy","year":"2017","journal-title":"Pharm. Res."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Jonczyk-Matysiak, E., Weber-Dabrowska, B., Owczarek, B., Miedzybrodzki, R., Lusiak-Szelachowska, M., Lodej, N., and Gorski, A. (2017). Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics. Viruses, 9.","DOI":"10.3390\/v9060150"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1128\/JVI.02043-14","article-title":"Immunogenicity studies of proteins forming the T4 phage head surface","volume":"88","author":"Dabrowska","year":"2014","journal-title":"J. Virol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"3612015","DOI":"10.1155\/2017\/3612015","article-title":"In Vivo Studies on the Influence of Bacteriophage Preparations on the Autoimmune Inflammatory Process","volume":"2017","author":"Miedzybrodzki","year":"2017","journal-title":"Biomed Res. Int."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"14802","DOI":"10.1038\/srep14802","article-title":"Mammalian Host-Versus-Phage immune response determines phage fate in vivo","volume":"5","author":"Miernikiewicz","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Singla, S., Harjai, K., Katare, O.P., and Chhibber, S. (2016). Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153777"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1146\/annurev-virology-100114-054915","article-title":"Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials","volume":"2","author":"Vandenheuvel","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.addr.2018.08.001","article-title":"Phage therapy for respiratory infections","volume":"133","author":"Chang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fcimb.2012.00118","article-title":"Pharmaceutical aerosols for the treatment and prevention of tuberculosis","volume":"2","author":"Hanif","year":"2012","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1038\/s41598-017-08336-9","article-title":"Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages","volume":"7","author":"Clement","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.chom.2019.01.008","article-title":"Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis","volume":"25","author":"Gogokhia","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/01902148.2013.873841","article-title":"Titer dynamic analysis of D29 within MTB-infected macrophages and effect on immune function of macrophages","volume":"40","author":"Xiong","year":"2014","journal-title":"Exp. Lung Res."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.virol.2012.09.002","article-title":"Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh","volume":"434","author":"Sarker","year":"2012","journal-title":"Virology"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Petrovic Fabijan, A., Lin, R.C.Y., Ho, J., Maddocks, S., Ben Zakour, N.L., Iredell, J.R., and Westmead Bacteriophage Therapy Team (2020). Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat. Microbiol.","DOI":"10.1101\/619999"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/jac\/dkw083","article-title":"Bacteriophage therapy: A regulatory perspective","volume":"71","author":"Pelfrene","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1073\/pnas.1913234117","article-title":"Controlled phage therapy by photothermal ablation of specific bacterial species using gold nanorods targeted by chimeric phages","volume":"117","author":"Peng","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41596-020-0346-0","article-title":"Standardized bacteriophage purification for personalized phage therapy","volume":"15","author":"Luong","year":"2020","journal-title":"Nat. Protoc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/2\/735\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:10:41Z","timestamp":1760159441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/2\/735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":247,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["ijms22020735"],"URL":"https:\/\/doi.org\/10.3390\/ijms22020735","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]}}}